|
E.V. Pronin, T.M. Alekseeva, M.B. Antsiferov
The efficacy of pegvisomant in patients with acromegaly resistant to 1st generation somatostatin analogues
|
№4 / 2022
|
|
E.V. Pronin (1), M.B. Antsiferov (1), T.M. Alekseeva (1), V.S. Pronin (2)
Rational pharmacotherapy of acromegaly: focus on treatment adherence
|
№4 / 2021
|
|
M.B. Antsiferov (1), T.M. Alekseeva (1), A.V. Andreeva (2)
Current approaches to the diagnostics and treatment of acromegaly
|
№4 / 2019
|
|
M.B. Antsiferov (1), Zh.E. Belaya (2)
INCREASING THE DOSE OF SOMATOSTATIN ANALOGUES OF IN PATIENTS WITH ACTIVE FORM OF ACROMEGALY: LITERATURE REVIEW AND PROSPECTS FOR APPLICATION
|
№16 / 2017
|
|
M.B. Antsiferov (1), T.M. Alekseeva (1), V.S. Pronin (2)
MOSCOW REGISTRY OF PATIENTS WITH ACROMEGALY: LONG-TERM RESULTS OF OBSERVATIONS
|
№16 / 2016
|
|
V.A. Gorbunova
NEW POTENTIALS FOR THE USE OF SOMATOSTATIN ANALOGS IN NEUROENDOCRINE TUMORS
|
№8 / 2016
|
|
A.A. Markovich (1), M.B. Antsiferov (2)
NEW APPROACHES TO DIAGNOSIS AND TREATMENT OF NEUROENDOCRINE TUMORS
|
№17 / 2015
|
|
M.B. Antsiferov (1), V.S.Pronin (2)
THE USE OF CLINICAL AND LABORATORY PREDICTORS FOR PROGNOSTICATION OF ANTISECRETORY AND ANTIPROLIFERATIVE EFFECTS OF SOMATOSTATIN ANALOGUES DURING THE TREATMENT OF ACROMEGALY: REVIEW OF RECENT RESEARCH
|
№5 / 2015
|
|
M.B. Antsiferov (1), V.S. Pronin (2)
ANTITUMOR EFFECTS OF SOMATOSTATIN ANALOGUES IN SOMATOTROPH PITUITARY ADENOMAS: REVIEW OF RECENT RESEARCH
|
№5 / 2014
|
|
M.B. Antsiferov 1; V.S. Pronin 2; T.M. Alekseeva 1, L.G. Dorofeeva 1
EXPERIENCE OF MAINTENANCE OF MOSCOW REGISTER OF PATIENTS WITH ACROMEGALY: POTENTIALS FOR THE SOLUTION OF VARIOUS THERAPEUTIC PROBLEMS
|
№16 / 2013
|
|
Yu.E. Poteshkin, V.S. Pronin, E.Yu. Kotlyarevskaya, E.V. Pronin, M.E. Morozova
ROLE OF URSODEOXYCHOLIC ACID IN THE PREVENTION OF CHOLELITHIASIS DURING TREATMENT OF ACROMEGALY USING SOMATOSTATIN ANALOGUES
|
№10 / 2013
|
|
M. B. Antsiferov 1, V. S. Pronin 2, T.M.Alekseeva 1, L.G.Dorofeyeva 1
Present And Future Of Pharmacotherapy Of Acromegaly
|
№16 / 2012
|
Русский
